ADIAL PHARMACEUTICALS, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA, 22901
Mailing Address 1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA, 22901
Phone 434-422-9800
Fiscal Year End 1231
EIN 800667150
Financial Overview
FY2024
$5.04M
Total Assets
$976K
Total Liabilities
$4.08M
Stockholders' Equity
$3.75M
Cash & Equivalents
$-2.72
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 4, 2026 | View on SEC |
| 8-K Current report of material events | January 6, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | January 6, 2026 | View on SEC |
| 424B5 Prospectus supplement | December 19, 2025 | View on SEC |
| S-3 Shelf registration for future offerings | December 12, 2025 | View on SEC |
| 8-K Current report of material events | December 1, 2025 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | September 16, 2025 | View on SEC |
| 8-K Current report of material events | September 3, 2025 | View on SEC |
Material Events
8-K Other February 4, 2026
High Impact
- Preserves Nasdaq listing, which is vital for credibility and visibility.
- Ensures liquidity and facilitates future funding for clinical trials and operations.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.